Home

Farrell Simon, Chief Commercial Officer: Trevi Therapeutics TRVI Sell · Filed 25/03/12

Trade details

Type
Insider sale
Amount
$517,960.99
Shares · price
76,963 sh · $6.73 a share
Held after
81,250 sh
Trade date
25/03/10
Filed
25/03/12
Days to filing
2 days

Sold 48.6% of holdings

Share of holding sold
48.6%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/08~25/04/09

Farrell Simon's recent trades

  • Farrell Simon

    Sell10b5-1 planTrevi Therapeutics

    $31.1K

    Filed 25/03/12

  • Farrell Simon

    Planned sale10b5-1 planTrevi Therapeutics

    $548.9K

    Filed 25/03/10

Farrell Simon, Chief Officer — sold $518K of Trevi Therapeutics TRVI · 48.6% of holdings · 10b5-1 plan | Whalegun